DOCSLIB.ORG

Occurrence of Sulfatide As a Major Glycosphingolipid in WHHL Rabbit Serum Lipoproteins1

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Occurrence of Sulfatide As a Major Glycosphingolipid in WHHL Rabbit Serum Lipoproteins1 /. Biochem. 102, 83-92 (1987) Occurrence of Sulfatide as a Major Glycosphingolipid in WHHL Rabbit Serum Lipoproteins1 Atsushi HARA and Tamotsu TAKETOMI Downloaded from https://academic.oup.com/jb/article/102/1/83/782552 by guest on 27 September 2021 Department of Lipid Biochemistry, Institute of Cardiovascular Disease, Shinshu University School of Medicine, Matsumoto, Nagano 390 Received for publication, February 12, 1987 Glycosphingolipids in serum and lipoproteins from Watanabe hereditable hyper- lipidemic rabbit (WHHL rabbit), which is an animal model for human familial hypercholesterolemia (FH), were analyzed for the first time in this study. Chylo- microns and very low density, low density, and high density lipoproteins contained sulfatide as a major glycosphingolipid (12 nmol//imol total phospholipids (PL) in chylomicrons, 19nmol//imol PL in VLDL, 18 nmol//imol PL in LDL, and 14 nmol/ /*mol PL in HDL) with other minor glycosphingolipids such as glucosylceramide, galactosylceramide, GM3 ganglioside, lactosylceramide, and globotriaosylceramide. The concentration of sulfatide as a major glycosphingolipid in WHHL rabbit serum (121 nmol/ml) was much higher than that in normal rabbit serum (3 nmol/ml). Fatty acids of the sulfatides comprised mainly nonhydroxy fatty acids (C22, 23, and 24) and significant amounts of hydroxy fatty acids (about 10 %), whereas long chain bases of the sulfatides comprised mostly (4E>sphingenine with a significant amount of 4D-hydroxysphinganine (about 10%). Furthermore, sulfatides in the liver and small intestine from normal and WHHL rabbits (where serum lipoproteins are produced) were determined to amount to 260nmol/g liver in WHHL rabbit, 104 nmol/g liver in control rabbit, 99.6 nmol/g small intestine in WHHL rabbit, and 31.2nmol/g small intestine in control rabbit. Ceramide portions of the sulfatides in the liver were mainly composed of (4E)-sphingenine and nonhydroxy fatty acids, while those in the small intestine were mainly composed of 4D-hydroxysphinganine and hydroxy fatty acids. These results indicated that the sulfatides of serum lipo- proteins were mostly derived from the liver (90% of the total), and that the remaining sulfatides (10% of the total) might be derived from the small intestine. These two sulfatides, which have different ceramide portions, could be useful markers for metabolic and biosynthetic studies of various lipoproteins in WHHL rabbit, and thus would be helpful to further elucidate the relationship between hypercholesterol- emia and atherosclerosis in the rabbit. 1 This work was supported in part by Grant-in-Aid for Scientific Research (No. 61480126) from the Ministry of Education, Science and Culture of Japan. Vol. 102, No. 1, 1987 83 84 A. HARA and T. TAKETOMI Glucosylceramide, galactosylceramide, lactosylcer- was determined by gas-liquid chromatography (9). amide, globotriaosylceramide, globotetraosylcer- Phosphorus contents of lipoproteins were deter- amide, and GM3-ganglioside have been found in mined by the method of Bartlett (10). As already human plasma and its lipoproteins (1-3). There reported by the authors (II), aliquots of various are some reports on increased levels of glyco- lipoproteins were negatively stained with phos- sphingolipids in serum; for example, an increase photungstic acid (pH 7.2) and dried on collodion of glucosylceramide in Gaucher patients and an carbon grids for electron-microscopic observation increase of globotriaosylceramide in Fabry patients (Hitachi, model Hu-ILA). These aliquots were (4). It was also reported that the levels of plasma also subjected to electrophoresis on Universal glycosphingolipids were elevated in patients with electrophoresis film (agarose) (Corning Medical, Downloaded from https://academic.oup.com/jb/article/102/1/83/782552 by guest on 27 September 2021 familial hypercholesterolemia (FH) (5, 6), but the U.S.A.). The lipoproteins were stained with Fat mechanism of the increase in glycosphingolipids red 7B or Coomassie brilliant blue R-250. Sodium remains to be solved. It is known that the WHHL dodecyl sulfate polyacrylamide gel electrophoresis rabbit is devoid of LDL-receptor, as is the case was performed according to Laemmli (12). The in FH. In the present study, we have analyzed procedures for extraction and isolation of glyco- glycosphingolipids in whole serum or lipoproteins sphingolipids were described in detail elsewhere in WHHL rabbit in order to further understand (9, 13). Briefly, Iipids were extracted from each the glycosphingolipid metabolism in FH. Al- lipoprotein fraction, whole serum, liver, or small though Coles and Foote have reported that plasma intestine with a chloroform-methanol mixture. lipoproteins in rabbit contained cerebroside, di- After alkaline treatment to cleave ester Iipids, glycosylceramide, triglycosylceramide, and globo- sphingolipids were separated into neutral sphin- side (7), more detailed information about glyco- golipids and acidic sphingolipids with DEAE- sphingolipids of plasma lipoproteins is needed to Sephadex A-25 (acetate form) as described by elucidate the glycosphingolipid metabolism in lipo- Ledeen et al. (14). The neutral glycosphingolipids proteins. In this paper, it is reported for the first were acetylated and separated into glycosphingo- time that the sulfatide content is highest in the lipids and sphingomyelin by silica gel column glycosphingolipid constituents in the serum lipo- chromatography and the glycosphingolipids were protein of WHHL rabbit, although the sulfatide finally deacetylated. The neutral glycosphingo- is seldom a major glycosphingolipid in other tis- lipids thus obtained were separated from each sues or fluids. other by preparative thin-layer chromatography (TLC) on plates precoated with Silica gel 60 (Merck, B.R.D.), developed with chloroform- MATERIALS AND METHODS methanol-water (65 : 25 : 4, v/v). The acidic Iipids were purified by silica gel column chromatography Materials—WHHL rabbits (Japanese white as follows; stepwise elution with chloroform- rabbit) were kindly supplied by Dr. Yoshio Wata- methanol mixtures (95 : 5, 90 : 10, 85 : 15, 80 : 20, nabe, Kobe University School of Medicine, Kobe. and 50 : 50) gave free fatty acids, sulfatide, and Normal rabbits (Japanese white rabbit) were used gangliosides. Sulfatide was further purified by as controls. Blood samples were drawn from the preparative TLC as above. Analytical procedures animals after overnight fasting and separated into used for the present study were described in detail sera and erythrocytes by centrifugation. The elsewhere (9, 13). Briefly, after methanolysis of pooled sera were used for experiments as well as glycosphingolipid, the resulting fatty acid methyl fresh tissues of rabbit liver and small intestine, esters were analyzed by gas liquid chromatography including mucous membrane. (GLQ using an OV-101 silicone capillary column Methods—The. pooled WHHL rabbit sera (0.2 mm x 25 m) at 25O°C. The methyl glycosides were fractionated into chylomicrons (CM, rf<0.93 from the methanolyzate were re-N-acetylated and g/ml), very low density lipoprotein (VLDL, 1.01 > analyzed as trimethylsilyl (TMS) derivatives by </>0.93), low density lipoprotein (LDL, 1.06>d> GLC on an OV-101 silicone capillary column. 1.01), and high density lipoprotein (HDL, 1.15 > The column temperature was programmed from tf>1.08) by the method of Hatch and Lees (8). 190 to 260°C at 2°C/min. Mannitol was used as Cholesterol content in each lipoprotein fraction J. Biochem. SULFAT1DE IN SERUM LIPOPROTE1NS 85 an internal standard. Long chain bases were lipoproteins were determined by electronmicro- prepared as before (13), and analyzed as TMS- scopic examination. As shown in Fig. 1, the derivatives by GLC on an OV-101 silicone capillary diameters of LDL and VLDL were 17-20 nm and column at 25O°C. The amount of ganglioside was 33-58 nm, respectively. These lipoproteins were determined with resorcinol reagent (75) or quan- also confirmed by electrophoresis on agarose film titated by TLC-densitometry at 570 nm (16). (data not shown). Simple lipid compositions of VLDL and LDL were determined by GLC anal- ysis of cholesterol or fatty acid methyl ester. RESULTS VLDL contained 54% cholesterol ester, 35% tri- Fractionation of Various Lipoproteins—The glyceride, and 11 % free cholesterol, while LDL Downloaded from https://academic.oup.com/jb/article/102/1/83/782552 by guest on 27 September 2021 pooled sera of fasting WHHL rabbits were frac- contained 62% cholesterol ester, 23% triglyceride, tionated into CM, VLDL, LDL, and HDL by the and 15% free cholesterol. procedure of Hatch and Lees (8). The lipoprotein Glycosphingolipids in Serum, and CM, VLDL, composition of the WHHL rabbit sera was deter- LDL, and HDL—Crude sphingolipids were sepa- mined on the basis of cholesterol content as fol- rated into neutral and acidic sphingolipids on lows: CM (1.9%), VLDL (24.5%), LDL (71.4%), DEAE-Sephadex A-25. After sphingomyelin was and HDL (2.2%). The size and shape of these removed from the neutral sphingolipid, relatively Vi.Di LDL Fig. I. Electron micrographs of VLDL and LDL. Each lipoprotein was negatively stained with phosphotungstic acid and dried on a collodion carbon grid. Vol. 102, No. I, 1987 86 A. HARA and T. TAKETOMI small amounts of neutral glycosphingolipids were major glycosphingolipid revealed that galactose obtained. They were separated from each other was the only component. The IR spectrum of by preparative TLC and identified by GLC anal- the glycosphingolipid was similar to that of sul- ysis of TMS derivatives
Load more

Recommended publications
  • Sphingolipid Metabolism Diseases ⁎ Thomas Kolter, Konrad Sandhoff
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Biochimica et Biophysica Acta 1758 (2006) 2057–2079 www.elsevier.com/locate/bbamem Review Sphingolipid metabolism diseases ⁎ Thomas Kolter, Konrad Sandhoff Kekulé-Institut für Organische Chemie und Biochemie der Universität, Gerhard-Domagk-Str. 1, D-53121 Bonn, Germany Received 23 December 2005; received in revised form 26 April 2006; accepted 23 May 2006 Available online 14 June 2006 Abstract Human diseases caused by alterations in the metabolism of sphingolipids or glycosphingolipids are mainly disorders of the degradation of these compounds. The sphingolipidoses are a group of monogenic inherited diseases caused by defects in the system of lysosomal sphingolipid degradation, with subsequent accumulation of non-degradable storage material in one or more organs. Most sphingolipidoses are associated with high mortality. Both, the ratio of substrate influx into the lysosomes and the reduced degradative capacity can be addressed by therapeutic approaches. In addition to symptomatic treatments, the current strategies for restoration of the reduced substrate degradation within the lysosome are enzyme replacement therapy (ERT), cell-mediated therapy (CMT) including bone marrow transplantation (BMT) and cell-mediated “cross correction”, gene therapy, and enzyme-enhancement therapy with chemical chaperones. The reduction of substrate influx into the lysosomes can be achieved by substrate reduction therapy. Patients suffering from the attenuated form (type 1) of Gaucher disease and from Fabry disease have been successfully treated with ERT. © 2006 Elsevier B.V. All rights reserved. Keywords: Ceramide; Lysosomal storage disease; Saposin; Sphingolipidose Contents 1. Sphingolipid structure, function and biosynthesis ..........................................2058 1.1.
    [Show full text]
  • A Mouse B16 Melanoma Mutant Deficient in Glycolipids
    Proc. Natl. Acad. Sci. USA Vol. 91, pp. 2703-2707, March 1994 Biochemistry A mouse B16 melanoma mutant deficient in glycolipids (glucosyltransferase/glucosylceramide/glucocerebroside) SHINICHI ICHIKAWA*t, NOBUSHIGE NAKAJO*, HISAKO SAKIYAMAt, AND YOSHIo HIRABAYASHI* *Laboratory for Glyco Cell Biology, Frontier Research Program, The Institute of Chemical and Physical Research (RIKEN), 2-1 Hirosawa, Wako-shi, Saitama 351-01, Japan; and *Division of Physiology and Pathology, National Institute of Radiological Sciences, 4-9-1 Anagawa, Chiba-shi, Chiba 260, Japan Communicated by Saul Roseman, December 21, 1993 ABSTRACT Mouse B16 melanoma cell line, GM-95 (for- cosyltransferase would provide an ideal tool. Although sev- merly designated as MEC-4), deficient in sialyllactosylceram- eral glycosylation mutant cells have been isolated by treat- ide was examined for its primary defect. Glycolipids from the ment with a mutagen followed by selection with lectins, mutant cells were analyzed by high-performance TLC. No defects in these mutants were involved in either glycoprotein glycolipid was detected in GM-95 cells, even when total lipid syntheses (for review, see ref. 3), nucleotide sugar syntheses, from 107 cells was analyzed. In contrast, the content of or nucleotide sugar transporters (4). Mutants defective in ceramide, a precursor lipid molecule of glycolipids, was nor- glycolipid-specific transferases have rarely been found. Re- mal. Thus, the deficiency of glycolipids was attributed to the cently, Tsuruoka et al. (5) isolated a mouse mammary car- first glucosylation step of ceramide. The ceramide glucosyl- cinoma mutant that gained GM3 expression by selection with transferase (EC 2.4.1.80) activity was not detected in GM-95 antilactosylceramide (anti-LacCer) monoclonal antibody cells.
    [Show full text]
  • Regulation of Glycolipid Synthesis in HL-60 Cells by Antisense
    Proc. Natl. Acad. Sci. USA Vol. 92, pp. 8670-8674, September 1995 Neurobiology Regulation of glycolipid synthesis in HL-60 cells by antisense oligodeoxynucleotides to glycosyltransferase sequences: Effect on cellular differentiation (gangliosides/gene expression/cell maturation) GuicHAo ZENG, TOSHlo ARIGA, XIN-BIN Gu, AND ROBERT K. Yu* Department of Biochemistry and Molecular Biophysics, Medical College of Virginia, Virginia Commonwealth University, Richmond, VA 23298-0614 Communicated by Saul Roseman, Johns Hopkins University, Baltimore, MD, June 8, 1995 ABSTRACT Treatment of the human promyelocytic leuke- Gal1-Gic-Cer mia cell line HL-60 with antisense oligodeoxynucleotides to UDP-N-acetylgalactosamine: 3-1,4-N-acetylgalactosaminyl- transferase (GM2-synthase; EC 2.4.1.92) and CMP-sialic acid:a- GGM3 synd8s EC 2.4.99.8) sequences ef- 2,8-sialyltransferase (GD3-synthase; Gal-Glc-Cer GD3 synthase Grl-Glc-Cer fectively down-regulated the synthesis of more complex ganglio- SA - SA sides in the ganglioside synthetic pathways after GM3, resulting cm sA aon in a remarkable increase in endogenous GM3 with concomitant decreases in more complex gangliosides. The treated cells un- GM2 synthase derwent monocytic differentiation as judged by morphological clwiges, adherent ability, and nitroblue tetrazolium staining. GaiNAc-Gal-Glc-Cer GaINAc-Gal-Glc-Cer SA These data provide evidence that the increased endogenous sk Q ganglioside GM3 may play an important role in regulating IGM2 SA cellular differentiation and that the antisense DNA technique proves to be a powerful tool in manipulating glycolipid synthesis GalGaNAc-Ca-Glc-Cer Gal-GaINAc-Gal-Glc-Cer in the cell. SA SA SA GDlb The composition of gangliosides-in cells undergoes dramatic changes during cellular growth, differentiation, and oncogenic transformation, suggesting a specific role of gangliosides in the Gal-GaINAc-Gal-Gic-Cer Gal-GaINAc-Gal-Glc-Cer regulation of these cellular events (3-5).
    [Show full text]
  • Sphingolipids and Cell Signaling: Relationship Between Health and Disease in the Central Nervous System
    Preprints (www.preprints.org) | NOT PEER-REVIEWED | Posted: 6 April 2021 doi:10.20944/preprints202104.0161.v1 Review Sphingolipids and cell signaling: Relationship between health and disease in the central nervous system Andrés Felipe Leal1, Diego A. Suarez1,2, Olga Yaneth Echeverri-Peña1, Sonia Luz Albarracín3, Carlos Javier Alméciga-Díaz1*, Angela Johana Espejo-Mojica1* 1 Institute for the Study of Inborn Errors of Metabolism, Faculty of Science, Pontificia Universidad Javeriana, Bogotá D.C., 110231, Colombia; [email protected] (A.F.L.), [email protected] (D.A.S.), [email protected] (O.Y.E.P.) 2 Faculty of Medicine, Universidad Nacional de Colombia, Bogotá D.C., Colombia; [email protected] (D.A.S.) 3 Nutrition and Biochemistry Department, Faculty of Science, Pontificia Universidad Javeriana, Bogotá D.C., Colombia; [email protected] (S.L.A.) * Correspondence: [email protected]; Tel.: +57-1-3208320 (Ext 4140) (C.J.A-D.). [email protected]; Tel.: +57-1-3208320 (Ext 4099) (A.J.E.M.) Abstract Sphingolipids are lipids derived from an 18-carbons unsaturated amino alcohol, the sphingosine. Ceramide, sphingomyelins, sphingosine-1-phosphates, gangliosides and globosides, are part of this group of lipids that participate in important cellular roles such as structural part of plasmatic and organelle membranes maintaining their function and integrity, cell signaling response, cell growth, cell cycle, cell death, inflammation, cell migration and differentiation, autophagy, angiogenesis, immune system. The metabolism of these lipids involves a broad and complex network of reactions that convert one lipid into others through different specialized enzymes. Impairment of sphingolipids metabolism has been associated with several disorders, from several lysosomal storage diseases, known as sphingolipidoses, to polygenic diseases such as diabetes and Parkinson and Alzheimer diseases.
    [Show full text]
  • GM2 Gangliosidoses: Clinical Features, Pathophysiological Aspects, and Current Therapies
    International Journal of Molecular Sciences Review GM2 Gangliosidoses: Clinical Features, Pathophysiological Aspects, and Current Therapies Andrés Felipe Leal 1 , Eliana Benincore-Flórez 1, Daniela Solano-Galarza 1, Rafael Guillermo Garzón Jaramillo 1 , Olga Yaneth Echeverri-Peña 1, Diego A. Suarez 1,2, Carlos Javier Alméciga-Díaz 1,* and Angela Johana Espejo-Mojica 1,* 1 Institute for the Study of Inborn Errors of Metabolism, Faculty of Science, Pontificia Universidad Javeriana, Bogotá 110231, Colombia; [email protected] (A.F.L.); [email protected] (E.B.-F.); [email protected] (D.S.-G.); [email protected] (R.G.G.J.); [email protected] (O.Y.E.-P.); [email protected] (D.A.S.) 2 Faculty of Medicine, Universidad Nacional de Colombia, Bogotá 110231, Colombia * Correspondence: [email protected] (C.J.A.-D.); [email protected] (A.J.E.-M.); Tel.: +57-1-3208320 (ext. 4140) (C.J.A.-D.); +57-1-3208320 (ext. 4099) (A.J.E.-M.) Received: 6 July 2020; Accepted: 7 August 2020; Published: 27 August 2020 Abstract: GM2 gangliosidoses are a group of pathologies characterized by GM2 ganglioside accumulation into the lysosome due to mutations on the genes encoding for the β-hexosaminidases subunits or the GM2 activator protein. Three GM2 gangliosidoses have been described: Tay–Sachs disease, Sandhoff disease, and the AB variant. Central nervous system dysfunction is the main characteristic of GM2 gangliosidoses patients that include neurodevelopment alterations, neuroinflammation, and neuronal apoptosis. Currently, there is not approved therapy for GM2 gangliosidoses, but different therapeutic strategies have been studied including hematopoietic stem cell transplantation, enzyme replacement therapy, substrate reduction therapy, pharmacological chaperones, and gene therapy.
    [Show full text]
  • Ceramide and Related Molecules in Viral Infections
    International Journal of Molecular Sciences Review Ceramide and Related Molecules in Viral Infections Nadine Beckmann * and Katrin Anne Becker Department of Molecular Biology, University of Duisburg-Essen, 45141 Essen, Germany; [email protected] * Correspondence: [email protected]; Tel.: +49-201-723-1981 Abstract: Ceramide is a lipid messenger at the heart of sphingolipid metabolism. In concert with its metabolizing enzymes, particularly sphingomyelinases, it has key roles in regulating the physical properties of biological membranes, including the formation of membrane microdomains. Thus, ceramide and its related molecules have been attributed significant roles in nearly all steps of the viral life cycle: they may serve directly as receptors or co-receptors for viral entry, form microdomains that cluster entry receptors and/or enable them to adopt the required conformation or regulate their cell surface expression. Sphingolipids can regulate all forms of viral uptake, often through sphingomyelinase activation, and mediate endosomal escape and intracellular trafficking. Ceramide can be key for the formation of viral replication sites. Sphingomyelinases often mediate the release of new virions from infected cells. Moreover, sphingolipids can contribute to viral-induced apoptosis and morbidity in viral diseases, as well as virus immune evasion. Alpha-galactosylceramide, in particular, also plays a significant role in immune modulation in response to viral infections. This review will discuss the roles of ceramide and its related molecules in the different steps of the viral life cycle. We will also discuss how novel strategies could exploit these for therapeutic benefit. Keywords: ceramide; acid sphingomyelinase; sphingolipids; lipid-rafts; α-galactosylceramide; viral Citation: Beckmann, N.; Becker, K.A.
    [Show full text]
  • Review Sialic Acid-Specific Lectins: Occurrence, Specificity and Function
    Cell. Mol. Life Sci. 63 (2006) 1331–1354 1420-682X/06/121331-24 DOI 10.1007/s00018-005-5589-y Cellular and Molecular Life Sciences © Birkhäuser Verlag, Basel, 2006 Review Sialic acid-specific lectins: occurrence, specificity and function F. Lehmanna, *, E. Tiralongob and J. Tiralongoa a Institute for Glycomics, Griffith University (Gold Coast Campus), PMB 50 Gold Coast Mail Centre Australia 9726 (Australia), Fax: +61 7 5552 8098; e-mail: [email protected] b School of Pharmacy, Griffith University (Gold Coast Campus), PMB 50 Gold Coast Mail Centre Australia 9726 (Australia) Received 13 December 2005; received after revision 9 February 2006; accepted 15 February 2006 Online First 5 April 2006 Abstract. Sialic acids consist of a family of acidic nine- through specific interactions with lectins, a family of carbon sugars that are typically located at the terminal po- proteins that recognise and bind sugars. This review will sitions of a variety of glycoconjugates. Naturally occur- present a detailed overview of our current knowledge re- ring sialic acids show an immense diversity of structure, garding the occurrence, specificity and function of sialic and this reflects their involvement in a variety of biologi- acid-specific lectins, particularly those that occur in vi- cally important processes. One such process involves the ruses, bacteria and non-vertebrate eukaryotes. direct participation of sialic acids in recognition events Keywords. Sialic acid, lectin, sialoglycoconjugate, sialic acid-specific lectin, adhesin, infectious disease, immunology. Introduction [1, 2]. The largest structural variations of naturally occurring Sia are at carbon 5, which can be substituted with either an Sialic acids (Sia) are a family of nine-carbon a-keto acids acetamido, hydroxyacetamido or hydroxyl moiety to form (Fig.
    [Show full text]
  • Mouse Model of GM2 Activator Deficiency Manifests Cerebellar Pathology and Motor Impairment
    Proc. Natl. Acad. Sci. USA Vol. 94, pp. 8138–8143, July 1997 Medical Sciences Mouse model of GM2 activator deficiency manifests cerebellar pathology and motor impairment (animal modelyGM2 gangliosidosisygene targetingylysosomal storage disease) YUJING LIU*, ALEXANDER HOFFMANN†,ALEXANDER GRINBERG‡,HEINER WESTPHAL‡,MICHAEL P. MCDONALD§, KATHERINE M. MILLER§,JACQUELINE N. CRAWLEY§,KONRAD SANDHOFF†,KINUKO SUZUKI¶, AND RICHARD L. PROIA* *Section on Biochemical Genetics, Genetics and Biochemistry Branch, National Institute of Diabetes and Digestive and Kidney Diseases, ‡Laboratory of Mammalian Genes and Development, National Institute of Child Health and Development, and §Section on Behavioral Neuropharmacology, Experimental Therapeutics Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD 20892; †Institut fu¨r Oganische Chemie und Biochemie der Universita¨tBonn, Gerhard-Domagk-Strasse 1, 53121 Bonn, Germany; and ¶Department of Pathology and Laboratory Medicine, and Neuroscience Center, University of North Carolina, Chapel Hill, NC 27599 Communicated by Stuart A. Kornfeld, Washington University School of Medicine, St. Louis, MO, May 12, 1997 (received for review March 21, 1997) ABSTRACT The GM2 activator deficiency (also known as disorder, the respective genetic lesion results in impairment of the AB variant), Tay–Sachs disease, and Sandhoff disease are the the degradation of GM2 ganglioside and related substrates. major forms of the GM2 gangliosidoses, disorders caused by In humans, in vivo GM2 ganglioside degradation requires the defective degradation of GM2 ganglioside. Tay–Sachs and Sand- GM2 activator protein to form a complex with GM2 ganglioside. hoff diseases are caused by mutations in the genes (HEXA and b-Hexosaminidase A then is able to interact with the activator- HEXB) encoding the subunits of b-hexosaminidase A.
    [Show full text]
  • Prospects for Using Expression Patterns of Paramyxovirus Receptors As Biomarkers for Oncolytic Virotherapy
    cancers Review Prospects for Using Expression Patterns of Paramyxovirus Receptors as Biomarkers for Oncolytic Virotherapy Olga V. Matveeva 1,* and Svetlana A. Shabalina 2,* 1 Sendai Viralytics LLC, 23 Nylander Way, Acton, MA 01720, USA 2 National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, MD 20894, USA * Correspondence: [email protected] (O.V.M.); [email protected] (S.A.S.) Received: 27 October 2020; Accepted: 1 December 2020; Published: 5 December 2020 Simple Summary: Some non-pathogenic viruses that do not cause serious illness in humans can efficiently target and kill cancer cells and may be considered candidates for cancer treatment with virotherapy. However, many cancer cells are protected from viruses. An important goal of personalized cancer treatment is to identify viruses that can kill a certain type of cancer cells. To this end, researchers investigate expression patterns of cell entry receptors, which viruses use to bind to and enter host cells. We summarized and analyzed the receptor expression patterns of two paramyxoviruses: The non-pathogenic measles and the Sendai viruses. The receptors for these viruses are different and can be proteins or lipids with attached carbohydrates. This review discusses the prospects for using these paramyxovirus receptors as biomarkers for successful personalized virotherapy for certain types of cancer. Abstract: The effectiveness of oncolytic virotherapy in cancer treatment depends on several factors, including successful virus delivery to the tumor, ability of the virus to enter the target malignant cell, virus replication, and the release of progeny virions from infected cells. The multi-stage process is influenced by the efficiency with which the virus enters host cells via specific receptors.
    [Show full text]
  • Liposomal Nanovaccine Containing Α-Galactosylceramide and Ganglioside GM3 Stimulates Robust CD8+ T Cell Responses Via CD169+ Macrophages and Cdc1
    Article Liposomal Nanovaccine Containing α-Galactosylceramide and Ganglioside GM3 Stimulates Robust CD8+ T Cell Responses via CD169+ Macrophages and cDC1 Joanna Grabowska 1,†, Dorian A. Stolk 1,† , Maarten K. Nijen Twilhaar 1, Martino Ambrosini 1, Gert Storm 2,3,4, Hans J. van der Vliet 5,6, Tanja D. de Gruijl 5, Yvette van Kooyk 1 and Joke M.M. den Haan 1,* 1 Department of Molecular Cell Biology and Immunology, Amsterdam UMC, Cancer Center Amsterdam, Amsterdam Infection and Immunity Institute, Vrije Universiteit Amsterdam, 1081 HZ Amsterdam, The Netherlands; [email protected] (J.G.); [email protected] (D.A.S.); [email protected] (M.K.N.T.); [email protected] (M.A.); [email protected] (Y.v.K.) 2 Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, 3584 CG Utrecht, The Netherlands; [email protected] 3 Department of Biomaterials Science and Technology, University of Twente, 7500 AE Enschede, The Netherlands 4 Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore 5 Department of Medical Oncology, Amsterdam UMC, Cancer Center Amsterdam, Amsterdam Infection and Immunity Institute, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands; [email protected] (H.J.v.d.V.); [email protected] (T.D.d.G.) 6 Lava Therapeutics, 3584 CM Utrecht, The Netherlands * Correspondence: [email protected]; Tel.: +31-20-4448080 Citation: Grabowska, J.; Stolk, D.A.; † Authors contributed equally. Nijen Twilhaar, M.K.; Ambrosini, M.; Storm, G.; van der Vliet, H.J.; Abstract: Successful anti-cancer vaccines aim to prime and reinvigorate cytotoxic T cells and should de Gruijl, T.D.; van Kooyk, Y.; therefore comprise a potent antigen and adjuvant.
    [Show full text]
  • Download (Accessed on 10 December 2020)
    H OH metabolites OH Article Comprehensive Identification of Glycosphingolipids in Human Plasma Using Hydrophilic Interaction Liquid Chromatography— Electrospray Ionization Mass Spectrometry Karel Hoˇrejší 1,2, Robert Jirásko 1, Michaela Chocholoušková 1, Denise Wolrab 1, David Kahoun 2 and Michal Holˇcapek 1,* 1 Department of Analytical Chemistry, Faculty of Chemical Technology, University of Pardubice, Studentská 573, 532 10 Pardubice, Czech Republic; [email protected] (K.H.); [email protected] (R.J.); [email protected] (M.C.); [email protected] (D.W.) 2 Institute of Chemistry, Faculty of Science, University of South Bohemia in Ceskˇ é Budˇejovice,Branišovská 1760, 370 05 Ceskˇ é Budˇejovice,Czech Republic; [email protected] * Correspondence: [email protected]; Tel.: +420-466-037-087 Abstract: Glycosphingolipids (GSL) represent a highly heterogeneous class of lipids with many cellular functions, implicated in a wide spectrum of human diseases. Their isolation, detection, and comprehensive structural analysis is a challenging task due to the structural diversity of GSL molecules. In this work, GSL subclasses are isolated from human plasma using an optimized monophasic ethanol–water solvent system capable to recover a broad range of GSL species. Obtained Citation: Hoˇrejší,K.; Jirásko, R.; deproteinized plasma is subsequently purified and concentrated by C18-based solid-phase extraction Chocholoušková, M.; Wolrab, D.; (SPE). The hydrophilic interaction liquid chromatography coupled to electrospray ionization linear Kahoun, D.; Holˇcapek,M. ion trap tandem mass spectrometry (HILIC-ESI-LIT-MS/MS) is used for GSL analysis in the human Comprehensive Identification of plasma extract. Our results provide an in-depth profiling and structural characterization of glycosph- Glycosphingolipids in Human ingolipid and some phospholipid subclasses identified in the human plasma based on their retention Plasma Using Hydrophilic Interaction times and the interpretation of tandem mass spectra.
    [Show full text]
  • L-Glucosylceramide: Synthesis, Properties, and Resistance
    Proc. Natl. Acad. Sci. USA Vol. 76, No. 7, pp. 3083-3086, July 1979 Biochemistry L-Glucosylceramide: Synthesis, properties, and resistance to catabolism by glucocerebrosidase in vitro (glucocerebroside/Gaucher disease/animal model/chemical sphingolipidosis) ANDREW E. GAL, PETER G. PENTCHEV, JANICE M. MASSEY, AND ROSCOE 0. BRADY Developmental and Metabolic Neurology Branch, National Institutes of Neurological and Communicative Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20205 Contributed by Roscoe 0. Brady, March 16, 1979 ABSTRACT Procedures for the synthesis and radioactive activity by the administration of conduritol-3-epoxide to induce labeling of L-glucosylceramide are described. This compound a syndrome resembling Gaucher disease in mice (6). However, is a stereoisomeric analogue of D-glucosylceramide which oc- the quantity of glucosylceramide that accumulated in liver and curs in nature and accumulates in pathological quantity in the 2- to 3-fold than that in normal mice organs and tissues of patients with Gaucher disease. The prop- spleen was only greater erties of L-glucosylceramide that have been examined so far and is therefore far below that found in patients with Gaucher have been found to be indistinguishable from those of the nat- disease (4). In addition, the typical Gaucher bodies or tubular urally occurring glycolipid. However, L-glucosylceramide is structures characteristic of the disorder were not observed in completely refractory to enzymatic hydrolysis by purified pla- spleen, liver, or bone marrow of mice treated with this reagent cental glucocerebrosidase and enzyme(s) present in whole tissue (7). extracts. It is anticipated that L-glucosylceramide will be a disease model at uniquely useful substance for exploring pathogenetic processes Because of the lack of a suitable Gaucher in animal analogues of Gaucher disease.
    [Show full text]